Stock comparison
Perrigo
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
PRGO
Perrigo
Market cap
$1.55B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | PRGO | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 32F | 71B | UTHR |
| Benjamin Graham | 32F | 76B | UTHR |
| Philip Fisher | 20F | 76B | UTHR |
| Peter Lynch | 16F | 62C | UTHR |
| Joel Greenblatt | 19F | 46D | UTHR |
| Charlie Munger | 23F | 64C | UTHR |
| Terry Smith | 14F | 64C | UTHR |
Side-by-side metrics
| Metric | PRGO | UTHR |
|---|---|---|
| Market cap | $1.55B | $24.13B |
| P/E (TTM) | - | 19.2x |
| EV/EBIT | 14.5x | 15.2x |
| ROIC (TTM) | 3.37% | 18.81% |
| Gross margin | 34.17% | 86.58% |
| Net margin | -43.5% | 40.61% |
| Revenue CAGR 5y | 0.68% | 17.22% |
| EPS CAGR 5y | - | 29.84% |
| Debt / Equity | 1.5x | - |
| Dividend yield | 10.43% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PRGO leads on
- P/E (TTM)-vs 19.2x+104%
- Dividend yield10.43%vs 0.0%+100%
UTHR leads on
- Net margin40.61%vs -43.5%+193%
- Debt / Equity-vs 1.5x+100%
- Revenue CAGR 5y17.22%vs 0.68%+96%
- Market cap$24.13Bvs $1.55B+94%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.